Vaccine research for gonococcal infections: Where are we?

Sexually Transmitted Infections

Volumn 89, Issue SUPPL. 4, 2013, Pages

  Jerse, Ann E ^a   Deal, Carolyn D ^b  

^a Uniformed Services University of the Health Sciences   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; VACCINE;

ADAPTIVE IMMUNITY; ARTICLE; GONORRHEA; HUMAN; IMMUNIZATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL;

ANTIGEN; GONORRHOEA; IMMUNOLOGY; IMMUNOSUPPRESSION; VACCINATION;

ANIMALS; BACTERIAL VACCINES; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; GONORRHEA; IMMUNE EVASION; IMMUNOLOGIC MEMORY; MICE, TRANSGENIC; NEISSERIA GONORRHOEAE; TH1 CELLS;

EID: 84891841649     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2013-051225     Document Type: Article

References (35)

1. World Health Organization. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. 2012.
2. Hook EW, Handsfield HH. Gonococcal infections in the adult. In: Holmes KK, Sparling PF, Mardh P-A, et al. eds. Sexually Transmitted Diseases. New York, New York: McGraw-Hill, 1999:451-66.
3. Zhu W, Chen CJ, Thomas CE, et al. Vaccines for gonorrhea: Can we rise to the challenge? Front Microbiol 2011;2:124-37.
4. Morand PC, Tattevin P, Eugene E, et al. The adhesive property of the type IV pilus-associated component PilC1 of pathogenic Neisseria is supported by the conformational structure of the N-terminal part of the molecule. Mol Microbiol 2001;40:846-56. (Pubitemid 32523182)
5. Haghi F, Peerayeh SN, Siadat SD, et al. Recombinant outer membrane secretin PilQ (406-770) as a vaccine candidate for serogroup B Neisseria meningitidis. Vaccine 2012;30:1710-14.
6. Edwards JL, Brown EJ, Uk-Nham S, et al. A co-operative interaction between Neisseria gonorrhoeae and complement receptor 3 mediates infection of primary cervical epithelial cells. Cell Microbiol 2002;4:571-84.
7. Faulstich M, Bottcher JP, Meyer TF, et al. Pilus phase variation switches gonococcal adherence to invasion by caveolin-1-dependent host cell signaling. PLoS Pathog 2013;9:e1003373.
8. Falsetta ML, Steichen CT, McEwan AG, et al. The composition and metabolic phenotype of Neisseria gonorrhoeae biofilms. Front Microbiol 2011;2:75.
9. Clark VL, Knapp JS, Thompson S, et al. Presence of antibodies to the major anaerobically induced gonococcal outer membrane protein in sera from patients with gonococcal infections. Microb Pathog 1988;5:381-90. (Pubitemid 19013555)
10. Shewell LK, Ku SC, Schulz BL, et al. Recombinant truncated AniA of pathogenic Neisseria elicits a non-native immune response and functional blocking antibodies. Biochem Biophys Res Commun 2013;431:215-20.
11. Hobbs MM, Sparling PF, Cohen MS, et al. Experimental gonococcal infection in male volunteers: Cumulative experience with Neisseria gonorrhoeae strains FA1090 and MS11mkC. Front Microbiol 2011;2:123.
12. Jerse AE, Bash MC, Russell MW. Vaccines against gonorrhea: Current status and future challenges. Vaccine Published Online First: 6 Sep 2013. doi:10.1016/j. vaccine.2013.08.067
13. Pettersson A, Kortekaas J, Weynants VE, et al. Vaccine potential of the Neisseria meningitidis lactoferrin-binding proteins LbpA and LbpB. Vaccine 2006; 24:3545-57.
14. Noinaj N, Cornelissen CN, Buchanan SK. Structural insight into the lactoferrin receptors from pathogenic Neisseria. J Struct Biol 2013.
15. Zalucki YM, Cloward JM, Ohneck EA, et al. Function and regulation of Neisseria gonorrhoeae efflux pumps. In: Yu EW, Zhang Q, Brown MH, eds. Microbial Efflux Pumps: Current Research. Horizon Press, Inc, 2013:202-23.
16. Shell DM, Chiles L, Judd RC, et al. The Neisseria lipooligosaccharide- specific α-2,3-sialyltransferase is a surface-exposed outer membrane protein. Infect Immun 2002;70:3744-51. (Pubitemid 34666014)
17. Smith H, Parsons NJ, Cole JA. Sialylation of neisserial lipopolysaccharide: A major influence on pathogenicity. Microb Pathog 1995;19:365-77. (Pubitemid 26092169)
18. Jerse AE, Wu H, Packiam M, et al. Estradiol-treated female mice as surrogate hosts for Neisseria gonorrhoeae genital tract infections. Front Microbiol 2011;2:107.
19. Gulati S, Zheng B, Reed G, et al. Protection against vaginal colonization with Neisseria gonorrhoeae in mouse model by passive (2C7 mAb) and active immunizations using a peptide surrogate of the 2C7 LOS epitope. Abstracts of the 18th International Pathogenic Neisseria Conference, Wurzburg, Germany. Abstract #0118. 2012.
20. Ngampasutadol J, Rice PA, Walsh MT, et al. Characterization of a peptide vaccine candidate mimicking an oligosaccharide epitope of Neisseria gonorrhoeae and resultant immune responses and function. Vaccine 2006;24:157-70. (Pubitemid 41753003)
21. Serruto D, Bottomley MJ, Ram S, et al. The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigens. Vaccine 2012;30(Suppl 2):B87-97.
22. Hadad R, Jacobsson S, Pizza M, et al. Novel meningococcal 4CMenB vaccine antigens-prevalence and polymorphisms of the encoding genes in Neisseria gonorrhoeae. APMIS 2012;120:750-60.
23. Sadarangani M, Pollard AJ, Gray-Owen SD. Opa proteins and CEACAMs: Pathways of immune engagement for pathogenic Neisseria. FEMS Microbiol Rev 2011;35:498-514.
24. Bode C, Zhao G, Steinhagen F, et al. CpG DNA as a vaccine adjuvant. Expert Rev Vaccines 2011;10:499-511.
25. Thompson AL, Staats HF. Cytokines: The future of intranasal vaccine adjuvants. Clin Dev Immunol 2011;2011:289597.
26. Cole JG, Jerse AE. Functional characterization of antibodies against Neisseria gonorrhoeae opacity protein loops. PLoS One 2009;4:e8108.
27. Serino L, Nesta B, Leuzzi R, et al. Identification of a new OmpA-like protein in Neisseria gonorrhoeae involved in the binding to human epithelial cells and in vivo colonization. Mol Microbiol 2007;64:1391-403. (Pubitemid 46849023)
28. Price GA, Masri HP, Hollander AM, et al. Gonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in mice. Vaccine 2007;25:7247-60. (Pubitemid 47464665)
29. Cornelissen CN, Hollander A. TonB-dependent transporters expressed by Neisseria gonorrhoeae. Front Microbiol 2011;2:117.
30. Stork M, Bos MP, Jongerius I, et al. An outer membrane receptor of Neisseria meningitidis involved in zinc acquisition with vaccine potential. PLoS Pathog 2010;6:e1000969.
31. Massari P, Ram S, Macleod H, et al. The role of porins in neisserial pathogenesis and immunity. Trends Microbiol 2003;11:87-93. (Pubitemid 36207505)
32. Gulati S, Agarwal S, Vasudhev S, et al. Properdin is critical for antibody-dependent bactericidal activity against Neisseria gonorrhoeae that recruit C4b-binding protein. J Immunol 2012;188:3416-25.
33. Keiser PB, Biggs-Cicatelli S, Moran EE, et al. A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression. Vaccine 2011;29:1413-20.
34. Zhu P, Klutch MJ, Derrick JP, et al. Identification of opcA gene in Neisseria polysaccharea: Interspecies diversity of Opc protein family. Gene 2003; 307:31-40. (Pubitemid 36428860)
35. Martin D, Cadieux N, Hamel J, et al. Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection. J ExpMed 1997; 185:1173-83. (Pubitemid 27172898)